InsiderClue
Stocks · Health care · Services-Offices & Clinics of Doctors of Medicine

SBC Medical Group Holdings Inc

SBC Clue Score53
United States Fiscal year ends December CIK 0001930313
$5.42 +1.50% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $5.42 +29.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 18 Sep 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue193.5Operating income70.7Net income39.4EPS, diluted0.42Fiscal year 2024Revenue205.4 +6.1%Operating income70.3Net income46.6 +18.4%EPS, diluted0.48 +14.3%Fiscal year 2025Revenue173.6 −15.5%Operating income67.5Net income51.0 +9.4%EPS, diluted0.50 +4.2%
FY2023FY2024FY2025
Revenue 193.5 205.4 173.6
Growth +6.1% −15.5%
Operating income 70.7 70.3 67.5
Net income 39.4 46.6 51.0
Growth +18.4% +9.4%
EPS, diluted 0.42 0.48 0.50
Growth +14.3% +4.2%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Gross margin70.9%Operating margin36.5%Net margin20.3%Free cash flow margin21.8%Fiscal year 2024Gross margin76.0%Operating margin34.2%Net margin22.7%Free cash flow margin8.8%Fiscal year 2025Gross margin73.3%Operating margin38.9%Net margin29.4%Free cash flow margin13.4%
FY2023FY2024FY2025
Gross margin 70.9% 76.0% 73.3%
Operating margin 36.5% 34.2% 38.9%
Net margin 20.3% 22.7% 29.4%
Free cash flow margin 21.8% 8.8% 13.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow50.7Capital expenditure−8.5Free cash flow42.1Fiscal year 2024Operating cash flow20.6Capital expenditure−2.6Free cash flow18.0 −57.2%Buybacks0.0Fiscal year 2025Operating cash flow24.7Capital expenditure−1.4Free cash flow23.3 +29.1%Buybacks−5.0
FY2023FY2024FY2025
Operating cash flow 50.7 20.6 24.7
Capital expenditure −8.5 −2.6 −1.4
Free cash flow 42.1 18.0 23.3
Growth −57.2% +29.1%
Buybacks n/a 0.0 −5.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2023Cash103.0Shareholders’ equity142.2Fiscal year 2024Cash125.0Total debt6.6Net cash (debt)118.4Shareholders’ equity195.1Debt to equity0.03Fiscal year 2025Cash163.8Total debt42.8Net cash (debt)120.9Shareholders’ equity248.3Debt to equity0.17
FY2023FY2024FY2025
Cash 103.0 125.0 163.8
Total debt n/a 6.6 42.8
Net cash (debt) n/a 118.4 120.9
Shareholders’ equity 142.2 195.1 248.3
Debt to equity n/a 0.03 0.17

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
193.5 205.4 173.6
Growth +6.1% −15.5%
56.2 49.4 46.3
137.3 156.1 127.3
Growth +13.7% −18.4%
66.2 57.7 59.8
70.7 70.3 67.5
Growth −0.5% −4.0%
73.6 73.5 82.1
35.0 26.8 31.0
39.4 46.6 51.0
Growth +18.4% +9.4%
Per share
0.42 0.48 0.50
0.42 0.48 0.50
Growth +14.3% +4.2%
94.2 96.6 103.0
94.2 96.6 103.0
Growth +2.5% +6.7%

Five years in brief

Worked out from the figures above, not from a press release
  • Profitable in every one of the 3 years on file.